This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Isenberg, D Search for Related Content PubMed PubMed Citation Articles by Isenberg, D Social Bookmarking                         What's this?

Anti-dsDNA antibodies: still a useful criterion for patients with systemic lupus erythematosus?

Centre for Rheumatology, Department of Medicine, UCL London, UK, d.isenberg{at}ucl.ac.uk

The presence of antibodies to dsDNA has been a criterion for systemic lupus erythematosus (SLE) in each of three attempts to classify the disease that have been undertaken by the American College of Rheumatology. The generally good specificity of the test, the fact that it is widely available and often undertaken by an enzyme linked immunosorbent assay (ELISA) which is relatively cheap and easy to perform have encouraged its continued presence in the list of lupus criteria. The detection of anti-dsDNA antibodies is not, however, straightforward and the real significance of the presence of these antibodies, their true specificity (or otherwise), the question of whether they are truly linked to disease pathogenicity and how accurately they reflect disease activity are all questions that have been posed in the past 20 years.

Key Words: anti-DNA antibodies • criteria • Farr assay • SLE

Lupus, Vol. 13, No. 11, 881-885 (2004)
DOI: 10.1191/0961203304lu2028oa


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				A Souza, L. da Silva, F. Oliveira, A. Roselino, and P Louzada-Junior Anti-nucleosome and anti-chromatin antibodies are present in active systemic lupus erythematosus but not in the cutaneous form of the disease Lupus, March 1, 2009; 18(3): 223 - 229. [Abstract] [PDF]

				L. Tucker Review: Making the diagnosis of systemic lupus erythematosus in children and adolescents Lupus, August 1, 2007; 16(8): 546 - 549. [Abstract] [PDF]

				K. Papp, Z. Szekeres, N. Terenyi, A. Isaak, A. Erdei, and J. Prechl On-chip Complement Activation Adds an Extra Dimension to Antigen Microarrays Mol. Cell. Proteomics, January 1, 2007; 6(1): 133 - 140. [Abstract] [Full Text] [PDF]

				H-P Jaekel, A Trabandt, N Grobe, and E Werle Anti-dsDNA antibody subtypes and anti-C1q antibodies: toward a more reliable diagnosis and monitoring of systemic lupus erythematosus and lupus nephritis Lupus, June 1, 2006; 15(6): 335 - 345. [Abstract] [PDF]